BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Zafgen 

29 Newbury Street

Boston  Massachusetts  02116  U.S.A.
Phone: 617-236-0535 Fax: 617-249-0490


SEARCH JOBS





Segment
Start Up





 Company News
Zafgen (ZFGN) Appoints Global Head Of Medical Affairs And Global Head Of Regulatory 5/27/2015 7:11:19 AM
Zafgen (ZFGN) Reports First Quarter 2015 Financial Results 5/13/2015 8:51:57 AM
Zafgen (ZFGN) Presents Positive Safety And Efficacy Data From Phase II Trial Of Beloranib In Severe Obesity And Proof Of Concept Trial In Prader-Willi Syndrome At ECO 2015 5/8/2015 8:06:13 AM
Zafgen (ZFGN) Announces Oral And Poster Presentations At The 22nd European Congress On Obesity 5/7/2015 12:39:59 PM
Zafgen (ZFGN) To Host Conference Call To Discuss First Quarter 2015 Financial Results 5/6/2015 10:41:01 AM
Zafgen (ZFGN) Reports Fourth Quarter And Full Year 2014 Financial Results 3/20/2015 7:27:09 AM
Zafgen (ZFGN) To Host Conference Call To Discuss Fourth Quarter And Full Year 2014 Financial Results 3/13/2015 7:31:07 AM
Zafgen (ZFGN) Announces New Weight Loss And Safety Data From Phase II Trial Of Beloranib In Hypothalamic Injury Associated Obesity At ENDO 2015 3/9/2015 7:27:18 AM
Zafgen (ZFGN) Joins NORD To Support Rare Disease Day 2/27/2015 7:56:48 AM
Zafgen (ZFGN) To Present At Cowen and Company 35th Annual Health Care Conference 2/27/2015 7:17:05 AM
1234567